6-BROMO-7-(DIMETHOXYMETHYL)-1,2,3,4-TETRAHYDRO-1,8-NAPHTHYRIDINE, 95.0%, 250mg

6-Chloro-3-(trifluoromethyl)pyridin-2-amine, 95.0%, 1g

2-[(1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-4-methyl-1H-pyrrole-3-propanoic acid, 95.0%, 10mg

(3aS,4R,6S,7R,7aR)-4-(Hydroxymethyl)-6-(4-methoxyphenoxy)-2,2-dimethyltetrahydro-4H-[1,3]dioxolo[4,5-c]pyran-7-ol, 97%, 5g

2-((2R)PYRROLIDIN-2-YL)-1,4-DIMETHOXYBENZENE, 95.0%, 1g

Ethyl 3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole-5-carboxylate, 98%, 250mg

2-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetic acid, 95.0%, 10g

Lead(II) Iodide (99.99%, trace metals basis) [for Perovskite precursor]>98.0%(T)100g

Indolizine, 95.0%, 5g

2,5-Diaminobenzonitrile, 97.0%, 5g

1-Boc-2-Methyl-4-piperidinone, 97.0%, 1g

Clotrimazole, 99.0%, 100g

1-(3-Bromo-4-methoxyphenyl)-2,2,2-trifluoroethan-1-ol, 95%, 250mg